Abstract:
Objective To analyze the expression of microRNA-338-3p (miR-338-3p) in serum of patients with unruptured intracranial aneurysms (UIAs) and its clinical implications.
Methods A total of 105 hospitalized patients with UIAs were selected as the observation group, and 100 subjects without intracranial aneurysms who underwent routine physical examination at the same period were selected as the control group.The fasting elbow vein blood of the patients in the observation group were collected on the first day after admission and those of the control group were collected in the morning of physical examination.The serum level of miR-338-3p, matrix metalloproteinase-2 (MMP-2) were measured, and the relationship between serum miR-338-3p and MMP-2, and the clinical characteristics of UIAs patients were analyzed according to Pearson correlation analysis.
Results The levels of serum miR-338-3p and MMP-2 in the observation group were higher than those in the control group (P < 0.01 and P < 0.05).There were significant differences in serum miR-338-3p and MMP-2 levels in UIAs patients with different aneurysm diameters and aneurysm numbers (P < 0.05 to P < 0.01).Pearson correlation analysis showed that there was a significant positive correlation between serum miR-338-3p and MMP-2 in UIAs patients (P < 0.01).
Conclusions The serum levels of miR-338-3p and MMP-2 in UIAs patients are elevated and correlated with the aneurysm diameter and number.